Home/Filings/4/0001012975-13-000443

4//SEC Filing

TETRAPHASE PHARMACEUTICALS INC 4

Accession 0001012975-13-000443

CIK 0001373707operating

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:40 PM ET

Size

19.3 KB

Accession

0001012975-13-000443

Insider Transaction Report

Form 4

Period: 2013-09-16

TETRAPHASE PHARMACEUTICALS INCTTPH

CMEA VENTURES VI LP

10% Owner

Transactions

Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total

CMEA Ventures VI GmbH & Co. KG

10% Owner

Transactions

Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total
Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total

CMEA Ventures VI Management, L.P.

10% Owner

Transactions

Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total
Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total

BARUCH THOMAS R

10% Owner

Transactions

Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total
Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total

Collier David J

10% Owner

Transactions

Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total
Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total

Sohail Faysal A.

10% Owner

Transactions

Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total
Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total

Watson James F

10% Owner

Transactions

Sale
Common Stock
2013-09-17$9.48/sh−8,012$75,954→ 2,104,911 total
Sale
Common Stock
2013-09-17$9.48/sh−192$1,820→ 50,327 total
Sale
Common Stock
2013-09-16$9.22/sh−44,207$407,589→ 2,112,923 total
Sale
Common Stock
2013-09-16$9.22/sh−1,057$9,746→ 50,519 total

Footnotes (2)

[F1]The shares are directly held by CMEA Ventures VI, L.P. ("CMEA VI"). The general partner of CMEA VI is CMEA Ventures VI Management, L.P. ("CMEA VI GP"). The general partners of CMEA VI GP are Thomas R. Baruch ("Baruch"), David J. Collier ("Collier"), Faysal A. Sohail ("Sohail"), and James F. Watson ("Watson") and, as such, each of these individuals exercises shared voting and investment power over the shares held of record by CMEA VI. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
[F2]The shares are directly held by CMEA Ventures VI GmbH & Co. KG ("CMEA VI GmbH"). The managing limited partner of CMEA VI GmbH is CMEA VI GP. The general partners of CMEA VI GP are Baruch, Collier, Sohail, and Watson and, as such, each of these individuals exercises shared voting and investment power over the shares held of record by CMEA VI GmbH. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001373707

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 5:40 PM ET
Size: 19.3 KB

View on SEC.gov